Loading...
XNASOPCH
Market cap4.11bUSD
Jan 08, Last price  
24.14USD
1D
0.84%
1Q
-16.06%
Jan 2017
2,221.15%
Name

Option Care Health Inc

Chart & Performance

D1W1MN
XNAS:OPCH chart
P/E
15.38
P/S
0.95
EPS
1.57
Div Yield, %
0.00%
Shrs. gr., 5y
41.33%
Rev. gr., 5y
43.42%
Revenues
4.30b
+9.06%
630,516,0001,073,235,0001,152,459,0001,197,732,0001,401,911,0001,329,525,0001,638,623,0001,818,026,000662,637,000842,195,000984,055,000982,223,000935,589,000817,190,000708,903,0002,310,417,0003,032,610,0003,438,640,0003,944,735,0004,302,324,000
Net income
267m
+77.40%
7,033,000-23,847,000-38,289,0003,317,000-74,032,00054,099,000-69,142,0007,872,00064,707,000-69,654,000-147,468,000-299,707,000-41,506,000-62,605,000-51,693,000-75,920,000-8,076,000139,898,000150,556,000267,090,000
CFO
371m
+38.78%
3,294,000-6,422,000-29,862,00024,187,000-8,746,00022,745,000-21,419,00026,969,00026,884,000-54,579,000-31,416,000-64,742,000-35,203,000-1,052,000-20,104,00039,467,000127,392,000208,569,000267,547,000371,295,000
Earnings
Feb 20, 2025

Profile

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
URL
https://optioncarehealth.com/
IPO date
Aug 15, 1996
Employees
5,597
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,302,324
9.06%
3,944,735
14.72%
Cost of revenue
3,321,101
3,077,817
Unusual Expense (Income)
NOPBT
981,223
866,918
NOPBT Margin
22.81%
21.98%
Operating Taxes
91,652
55,212
Tax Rate
9.34%
6.37%
NOPAT
889,571
811,706
Net income
267,090
77.40%
150,556
7.62%
Dividends
Dividend yield
Proceeds from repurchase of equity
(250,261)
BB yield
4.12%
Debt
Debt current
42,556
25,380
Long-term debt
1,245,896
1,149,025
Deferred revenue
Other long-term liabilities
81,124
Net debt
913,520
843,477
Cash flow
Cash from operating activities
371,295
267,547
CAPEX
(41,866)
(35,358)
Cash from investing activities
(56,506)
(108,052)
Cash from financing activities
(265,126)
15,268
FCF
778,632
810,965
Balance
Cash
343,849
294,186
Long term investments
31,083
36,742
Excess cash
159,816
133,691
Stockholders' equity
472,509
211,600
Invested Capital
2,446,546
2,417,120
ROIC
36.58%
35.00%
ROCE
37.15%
33.69%
EV
Common stock shares outstanding
180,375
182,075
Price
33.69
11.96%
30.09
5.80%
Market cap
6,076,834
10.92%
5,478,637
6.31%
EV
6,990,354
6,322,114
EBITDA
1,043,423
932,352
EV/EBITDA
6.70
6.78
Interest
51,248
53,806
Interest/NOPBT
5.22%
6.21%